Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Apr;48(4):339–343. doi: 10.1136/thx.48.4.339

Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.

M F Muers 1, C E Round 1
PMCID: PMC464429  PMID: 7685550

Abstract

BACKGROUND--Although most treatment for non-small cell lung cancer is palliative, data on the adequacy of symptom control are scanty and there has been little discussion about the appropriate indices. METHODS--Two hundred and eighty nine unselected patients presenting sequentially to six specialists were studied; 242 cases were confirmed histologically and all were managed as non-small cell lung cancer. At presentation and two monthly for one year or until death each of 12 symptoms was graded by a physician at a clinic interview on a four point scale as absent, mild, moderate, or severe. For each symptom a palliative index (median duration of control/median duration of survival) was calculated, where control was defined as an improvement in symptoms of any severity by one grade or more. RESULTS--Sixty four (22%) patients had surgery, 15 (5%) radical and 107 (37%) palliative radiotherapy, and 103 (36%) best supportive care. Analysis showed that most symptoms inexorably worsened with time. The palliation index for haemoptysis was 86%, chest pain 73%, cough 34%, and breathlessness 30%; for systemic symptoms it was 54% for anorexia and 47% for malaise. Palliation was poor in many patients after surgery. Breathlessness was a particular problem in the group having best supportive care. CONCLUSIONS--The frequency of most symptoms in non-small cell lung cancer increases inexorably with time until malaise and anorexia are almost universal. Haemoptysis and chest pain are better palliated than cough and breathlessness. Present treatments fail to give adequate palliation for many patients, and the emphasis in future therapeutic studies should be on the relief of the more severe symptoms.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coates A., Dillenbeck C. F., McNeil D. R., Kaye S. B., Sims K., Fox R. M., Woods R. L., Milton G. W., Solomon J., Tattersall M. H. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol. 1983 Nov;19(11):1633–1637. doi: 10.1016/0277-5379(83)90096-2. [DOI] [PubMed] [Google Scholar]
  2. Collins T. M., Ash D. V., Close H. J., Thorogood J. An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus. Clin Radiol. 1988 May;39(3):284–286. doi: 10.1016/s0009-9260(88)80536-1. [DOI] [PubMed] [Google Scholar]
  3. Connolly C. K., Jones W. G., Thorogood J., Head C., Muers M. F. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer. 1990 Apr;61(4):579–583. doi: 10.1038/bjc.1990.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Durrant K. R., Berry R. J., Ellis F., Ridehalgh F. R., Black J. M., Hamilton W. S. Comparison of treatment policies in inoperable bronchial carcinoma. Lancet. 1971 Apr 10;1(7702):715–719. doi: 10.1016/s0140-6736(71)91986-6. [DOI] [PubMed] [Google Scholar]
  5. Fergusson R. J., Cull A. Quality of life measurement for patients undergoing treatment for lung cancer. Thorax. 1991 Sep;46(9):671–675. doi: 10.1136/thx.46.9.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hamelmann H., Thermann M., Müller-Schwefe T., Schnürer C., Troidl H. Surgically treated bronchial carcinoma patients--results of systematic follow-up. Thorac Cardiovasc Surg. 1983 Feb;31(1):41–44. doi: 10.1055/s-2007-1020291. [DOI] [PubMed] [Google Scholar]
  7. Kaasa S., Mastekaasa A., Naess S. Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol. 1988;27(4):335–342. doi: 10.3109/02841868809093551. [DOI] [PubMed] [Google Scholar]
  8. Komaki R., Cox J. D., Hartz A. J., Byhardt R. W., Perez-Tamayo C., Clowry L., Choi H., Wilson F., Lopes da Conceicao A., Rangala N. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol. 1985 Oct;8(5):362–370. doi: 10.1097/00000421-198510000-00005. [DOI] [PubMed] [Google Scholar]
  9. Maguire P., Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989 Sep;60(3):437–440. doi: 10.1038/bjc.1989.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Maher E. J., Dische S., Grosch E., Fermont D., Ashford R., Saunders M., Makepeace A., Korn M., Shah D. Who gets radiotherapy? Health Trends. 1990;22(2):78–83. [PubMed] [Google Scholar]
  11. Nõu E., Aberg T. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax. 1980 Apr;35(4):255–263. doi: 10.1136/thx.35.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reuben D. B., Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986 Feb;89(2):234–236. doi: 10.1378/chest.89.2.234. [DOI] [PubMed] [Google Scholar]
  13. Slawson R. G., Scott R. M. Radiation therapy in bronchogenic carcinoma. Radiology. 1979 Jul;132(1):175–176. doi: 10.1148/132.1.175. [DOI] [PubMed] [Google Scholar]
  14. Twycross R. G. The terminal care of patients with lung cancer. Postgrad Med J. 1973 Oct;49(576):732–737. doi: 10.1136/pgmj.49.576.732. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES